SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 105 filers reported holding SERES THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $69,339 | -48.9% | 29,134 | +2.8% | 0.00% | 0.0% |
| Q2 2023 | $135,701 | -17.1% | 28,330 | -1.9% | 0.00% | 0.0% |
| Q1 2023 | $163,750 | +4.4% | 28,880 | +3.1% | 0.00% | -50.0% |
| Q4 2022 | $156,845 | -9.3% | 28,008 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $173,000 | +188.3% | 26,952 | +54.7% | 0.00% | +100.0% |
| Q2 2022 | $60,000 | -54.9% | 17,423 | -6.4% | 0.00% | 0.0% |
| Q1 2022 | $133,000 | -13.6% | 18,621 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $154,000 | +18.5% | 18,514 | -1.1% | 0.00% | 0.0% |
| Q3 2021 | $130,000 | -70.7% | 18,729 | +0.7% | 0.00% | -75.0% |
| Q2 2021 | $444,000 | +15.9% | 18,603 | +0.0% | 0.00% | +33.3% |
| Q1 2021 | $383,000 | -12.2% | 18,594 | +4.4% | 0.00% | -25.0% |
| Q4 2020 | $436,000 | – | 17,807 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $148,411,000 | 6.25% |
| Eversept Partners, LP | 1,935,825 | $12,427,997 | 1.08% |
| Kynam Capital Management, LP | 772,820 | $4,962,000 | 1.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 366,493 | $2,353,000 | 0.80% |
| Lion Point Capital, LP | 626,803 | $3,228,000 | 0.71% |
| FEDERATED HERMES, INC. | 18,499,136 | $118,765,000 | 0.35% |
| Knott David M Jr | 110,000 | $706,000 | 0.30% |
| Atom Investors LP | 108,820 | $699,000 | 0.25% |
| Ikarian Capital, LLC | 131,310 | $843,000 | 0.17% |
| HARVARD MANAGEMENT CO INC | 131,847 | $846,000 | 0.10% |